Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2025 ,inter alia, to consider and approve 1. To Approve Notice ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has informed BSE that its Board of Directors will meet on 14 October 2025 to approve a Postal Ballot notice. The key agenda item is the reclassification of M/s Akshath Finvest and Properties Private Limited from the 'Promoter/Promoter Group' category to the 'Public' category. This follows a No Objection Certificate received from BSE dated 26 September 2025. The trading window for insiders has been closed from 1 October 2025 until 48 hours after the announcement of Q2 FY26 financial results.
If shareholders approve the reclassification via Postal Ballot, the promoter group's reported shareholding will formally decrease, with Akshath Finvest's stake moving into the public shareholding category. This is a governance/restructuring event and not a stake sale; near-term stock price impact is likely limited unless it signals broader changes in promoter control.